Tyler Harris has a diverse work experience spanning several companies and roles. Starting in 2014, Harris worked as a Postdoctoral Research Associate at The Scripps Research Institute until 2015. Following that, Harris joined Theravance Biopharma, Inc. as a Medical Science Liaison from August 2015 to February 2016. In 2016, Harris began working at Biological Dynamics as a Scientist, progressing to the role of Scientist ll from June 2019 to March 2021, and finally becoming a Senior Scientist from March to September 2021. Harris then joined Roswell Biotechnologies as a Principal Scientist from October 2021 to May 2022. Currently, Harris holds the position of Principal Scientist at EXOKĒRYX, starting in May 2022, and has recently been promoted as the Head of Surface Chemistry from March 2023.
Tyler Harris earned a Bachelor's Degree in Chemistry from the University of North Carolina Wilmington in 2006. Tyler continued their education at the same institution and completed a Master's Degree in Chemistry between 2007 and 2009. Following this, Tyler pursued a Doctor of Philosophy (Ph.D.) in Organic Chemistry at North Carolina State University, graduating in 2013.
This person is not in any teams
EXOKĒRYX
We believe cancer kills too many people. Our mission is to change that. Today’s diagnostic methods are not good enough. They catch diseases too late. Researchers do not have the tools they need to find the signals for early disease detection and diagnosis. We are putting our breakthrough technology in the hands of leading researchers to speed up the fight against cancer. Exosomes are crucial to cellular communication within our bodies and hold the key to early cancer detection. At Exokeryx we are decoding the signals on exosomes to create a unique fingerprint for the cancers that kill 80% of people. Our upcoming blood test, the Cancer Fingerprint™, powered by our chip-based sensor, is sensitive and affordable, making it possible for everyone to be tested yearly for cancer. Together we can improve understanding, find cancer early, and save lives.